Healthcare -
Biotechnology - NASDAQ - US
$ 8.67
9.61 %
$ 738 M
Market Cap
-15.76
P/E
AVXL - OTHER CURRENT LIABILITIES
Other Current Liabilities AVXL - Anavex Life Sciences Corp.
4.84 M
LAST VALUE
-13.01%
2 YEAR CAGR
26.10%
5 YEAR CAGR
67.25%
10 YEAR CAGR